CRISPR Therapeutics vs Cystic Fibrosis Foundation
CRISPR Therapeutics vs Cystic Fibrosis Foundation, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and Cystic Fibrosis Foundation on 59/100.
Where each one leads
CRISPR Therapeutics
- our overall score: 64/100 against 59/100
- agent readiness: 44/100 against 25/100
- funding raised: $547M against $9.3M
Cystic Fibrosis Foundation
- domain rating: 80/100 against 67/100
At a glance
| Measure | CRISPR Therapeutics | Cystic Fibrosis Foundation |
|---|---|---|
| What it is | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. | A leading organization dedicated to curing and treating cystic fibrosis. |
| Category | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals | Biotechnology, Healthcare, Non-profit |
| Sells toBusiness model | B2B | B2G |
| Offering | Platform | Services |
| Founded | 2013 | 1955 |
| Headquarters | Zug, Switzerland | Bethesda, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | CRISPR Therapeutics | Cystic Fibrosis Foundation |
|---|---|---|
| Employees | Not published | 1,183 |
| Total funding | $547M | $9.3M |
| Latest round | Series B | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CRISPR Therapeutics | Cystic Fibrosis Foundation |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 59/100 |
| Traction | 40/100 | 55/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 13/100 | 2/100 |
| Quality | 88/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (25/100) |
| Domain ratingLink authority, 0-100 | 67/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CRISPR Therapeutics | Cystic Fibrosis Foundation |
|---|---|---|
| Hosting | Self Managed | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CRISPR Therapeutics vs Cystic Fibrosis Foundation: common questions
Which is better, CRISPR Therapeutics or Cystic Fibrosis Foundation?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do CRISPR Therapeutics and Cystic Fibrosis Foundation compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 59/100), agent readiness (44/100 against 25/100), funding raised ($547M against $9.3M). Cystic Fibrosis Foundation leads on domain rating (80/100 against 67/100).
Read the full CRISPR Therapeutics review and pricing or the Cystic Fibrosis Foundation review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.